Salarius Pharmaceuticals
SLRX
SLRX
6 hedge funds and large institutions have $13.4K invested in Salarius Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$13K |
| 2 |
SS
2
SBI Securities
Tokyo,
Japan
|
$2 |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| 2 |
2
Citigroup
New York
|
$0 |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$20 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $13K | 7,081 | +6,821 | +2,623% |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $297 | 162 | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $20 | 11 | -7 | -39% |
|
4
Morgan Stanley
New York
| $13 | 7 | – | – |
|
5
BlackRock
New York
| $2 | 1 | – | – |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $2 | 1 | +1 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | – | -3,189 | Closed |
|
|
8
Citigroup
New York
| – | – | -1,610 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|